Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleSpecial Communication

Thinking “Green” When Treating “Pink Puffers” and “Blue Bloaters”—Reducing Carbon Footprint When Prescribing Inhalers

Harland T. Holman, Michael J. Bouthillier and Frank Müller
The Journal of the American Board of Family Medicine April 2023, 36 (2) 356-359; DOI: https://doi.org/10.3122/jabfm.2022.220292R2
Harland T. Holman
From the Department of Family Medicine, Michigan State University, Grand Rapids, MI, USA (HTH, MJB, FM); Spectrum Health Family Medicine Residency Center, Grand Rapids, MI, USA (HTH, MJB, FM); College of Pharmacy, Ferris State University, Big Rapids, MI, USA (MJB); Department of General Practice, University Medical Center Göttingen, Göttingen, Germany (FM).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Bouthillier
From the Department of Family Medicine, Michigan State University, Grand Rapids, MI, USA (HTH, MJB, FM); Spectrum Health Family Medicine Residency Center, Grand Rapids, MI, USA (HTH, MJB, FM); College of Pharmacy, Ferris State University, Big Rapids, MI, USA (MJB); Department of General Practice, University Medical Center Göttingen, Göttingen, Germany (FM).
PharmD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Müller
From the Department of Family Medicine, Michigan State University, Grand Rapids, MI, USA (HTH, MJB, FM); Spectrum Health Family Medicine Residency Center, Grand Rapids, MI, USA (HTH, MJB, FM); College of Pharmacy, Ferris State University, Big Rapids, MI, USA (MJB); Department of General Practice, University Medical Center Göttingen, Göttingen, Germany (FM).
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    1. Rossati A
    . Global Warming and Its Health Impact. Int J Occup Environ Med 2017;8:7–20.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Eckelman MJ,
    2. Sherman J
    . Environmental Impacts of the U.S. Health Care System and Effects on Public Health. Ahmad S, ed. PLOS ONE 2016;11:e0157014.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Pichler PP,
    2. Jaccard IS,
    3. Weisz U,
    4. Weisz H
    . International comparison of health care carbon footprints. Environ Res Lett 2019;14:064004064004.
    OpenUrlCrossRef
  4. 4.↵
    1. Belkhir L,
    2. Elmeligi A
    . Carbon footprint of the global pharmaceutical industry and relative impact of its major players. J Clean Prod 2019;214:185–94.
    OpenUrlCrossRef
  5. 5.↵
    1. Richie C
    . Environmental sustainability and the carbon emissions of pharmaceuticals. J Med Ethics 2021;medethics-2020-106842. April 14.
  6. 6.↵
    1. Richie C
    . Can United States Healthcare Become Environmentally Sustainable? Towards Green Healthcare Reform. J Law Med Ethics 2020;48:643–52.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Pritchard JN
    . The climate is changing for metered-dose inhalers and action is needed. Drug Des Devel Ther 2020;14:3043–55.
    OpenUrl
  8. 8.↵
    About Montreal Protocol. Accessed August 9, 2022. Available from: https://www.unep.org/ozonaction/who-we-are/about-montreal-protocol.
  9. 9.↵
    1. Janson C,
    2. Henderson R,
    3. Löfdahl M,
    4. Hedberg M,
    5. Sharma R,
    6. Wilkinson AJ
    . Carbon footprint impact of the choice of inhalers for asthma and COPD. Thorax 2020;75:82–4.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Stocker T
    . Climate Change 2013: The Physical Science Basis: Working Group I Contribution to the Fifth Assessment Report of the Intergovernmental Panel on Climate Change. Cambridge University press; 2014.
  11. 11.↵
    1. Schmiemann G,
    2. Dörks M
    Klimabewusste Verordnung von inhalativen Arzneimitteln: DEGAM S1-Handlungsempfehlung: AWMF-Register-Nr. 053-059 Schmiemann G, Dörks M. Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin e.V., ed. Published online March 2022. Available from: https://www.degam.de/files/Inhalte/Leitlinien-Inhalte/Dokumente/DEGAM-S1-Handlungsempfehlung/053-059_%20Klimabewusste%20Verordnung%20von%20Inhalativa/053-059l_S1%20Klimabewusstes%20VO%20Inhalativa_16-05-2022.pdf.
  12. 12.↵
    US Department of Health and Human Services, ed. 2020 Focused Updates to the Asthma Management Guidelines: A report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. Published online 2020. Accessed November 8, 2022. Available from: https://www.nhlbi.nih.gov/sites/default/files/publications/AsthmaManagementGuidelinesReport-2-4-21.pdf.
  13. 13.↵
    Global Initiative for Chronic Obstructive Lung Disease, ed. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease - 2022 Report. Published online 2022. Accessed November 8, 2022. Available from: https://goldcopd.org/wp-content/uploads/2021/12/GOLD-REPORT-2022-v1.1-22Nov2021_WMV.pdf.
  14. 14.↵
    1. Darbà J,
    2. Ramírez G,
    3. Sicras A,
    4. García-Bujalance L,
    5. Torvinen S,
    6. Sánchez-de la Rosa R
    . Identification of factors involved in medication compliance: incorrect inhaler technique of asthma treatment leads to poor compliance. Patient Prefer Adherence 2016;10:135–45.
    OpenUrlPubMed
  15. 15.↵
    1. Sanchis J,
    2. Gich I,
    3. Pedersen S
    , Aerosol Drug Management Improvement Team (ADMIT). Systematic Review of Errors in Inhaler Use. Chest 2016;150:394–406.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Kocks JWH,
    2. Chrystyn H,
    3. van der Palen J,
    4. et al
    . Systematic Review of Association between Critical Errors in Inhalation and Health Outcomes in Asthma and COPD. Npj Prim Care Respir Med 2018;28:43.
    OpenUrl
  17. 17.↵
    1. Self TH,
    2. Arnold LB,
    3. Czosnowski LM,
    4. Swanson JM,
    5. Swanson H
    . Inadequate Skill of Healthcare Professionals in Using Asthma Inhalation Devices. J Asthma 2007;44:593–8.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Gillette C,
    2. Rockich-Winston N,
    3. Kuhn JA,
    4. Flesher S,
    5. Shepherd M
    . Inhaler Technique in Children With Asthma: A Systematic Review. Acad Pediatr 2016;16:605–15.
    OpenUrlPubMed
  19. 19.↵
    1. Mahler DA
    . Peak Inspiratory Flow Rate as a Criterion for Dry Powder Inhaler Use in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. Published online May 8, 2017:AnnalsATS.201702-156PS.
  20. 20.↵
    1. Marlon JR,
    2. Neyens L,
    3. Jefferson M,
    4. Howe P,
    5. Mildenberger M,
    6. Leiserowitz A
    . Yale Climate Opinion Maps 2021. Yale Climate Opinion Maps 2021. Published June 2015. Accessed August 29, 2022. Available from: http://www.nature.com/articles/nclimate2583.
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family     Medicine: 36 (2)
The Journal of the American Board of Family Medicine
Vol. 36, Issue 2
March/April 2023
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Thinking “Green” When Treating “Pink Puffers” and “Blue Bloaters”—Reducing Carbon Footprint When Prescribing Inhalers
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 7 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Thinking “Green” When Treating “Pink Puffers” and “Blue Bloaters”—Reducing Carbon Footprint When Prescribing Inhalers
Harland T. Holman, Michael J. Bouthillier, Frank Müller
The Journal of the American Board of Family Medicine Apr 2023, 36 (2) 356-359; DOI: 10.3122/jabfm.2022.220292R2

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Thinking “Green” When Treating “Pink Puffers” and “Blue Bloaters”—Reducing Carbon Footprint When Prescribing Inhalers
Harland T. Holman, Michael J. Bouthillier, Frank Müller
The Journal of the American Board of Family Medicine Apr 2023, 36 (2) 356-359; DOI: 10.3122/jabfm.2022.220292R2
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Teaching Point of Significant Clinical Relevance
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Primary Care Clinicians Attitude, Knowledge, and Willingness to Address Climate Change in Shared Decision-Making
  • Prescribing preferences and availability of nebulisers and inhalers for inhaled medications in bronchiectasis: results of a specialist survey
  • Research Representing the Changing Landscape of Family Medicine
  • Google Scholar

More in this TOC Section

  • In Defense of Generalists: Primary Care Observations Have Systematic Advantages
  • Looking Back to Move Forward: Reflections of PBRN Directors
  • Building a Primary Care Research Agenda for Latino Populations in the Setting of the Latino Paradox: A Report from the 2023 Latino Primary Care Summit
Show more Special Communication

Similar Articles

Keywords

  • Asthma
  • Carbon Dioxide
  • Carbon Footprint
  • Climate Change
  • COPD
  • Drug Prescriptions
  • Dry Powder Inhalers
  • Environmental Medicine
  • Family Medicine
  • Global Warming
  • Greenhouse Gases
  • Metered Dose Inhalers
  • Norflurane

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire